Answer
Tysabri (natalizumab) must not be combined with other disease-modifying therapies, as this combination is contraindicated.
Sources for this answer
- TYSABRI 300 mg concentrate for solution for infusionBiogen Idec Ltd · emc · SmPC §4.3 Contraindications · Version 43Document updated
Sources checked